Drugs News and Research

RSS

Researchers describe how to assess if an antibiotic has a new mechanism of action

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents.

19 Oct 2020

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

‘KNAUER Wissenschaftliche Geräte GmbH’ and its new subsidiary 'Das Labor. GmbH' produce reliable Corona antibody tests in Sub-Saharan Africa.

From KNAUER Wissenschaftliche Geräte GmbH 19 Oct 2020

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.

18 Oct 2020

Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Multidrug resistance (MDR) -- a process in which tumors become resistant to multiple medicines -- is the main cause of failure of cancer chemotherapy.

16 Oct 2020

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Antispastic drug candidate could offer new hope for millions of patients suffering from spasticity

First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients suffering from spasticity.

16 Oct 2020

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Scientists from the University of Sheffield and University of Manchester have been awarded £265,000 from the British Heart Foundation, to investigate the links between vascular dementia and heart disease, and test whether a drug currently used to treat arthritis could also be used as a treatment for vascular dementia.

16 Oct 2020

Study uncovers novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness

During metastasis, cancer cells actively interact with microenvironments of new tissues. How metastatic cancer cells respond to new environments in the secondary tissues is a crucial question in cancer research but still remains elusive.

16 Oct 2020

Researchers develop new strategy to improve siRNA stability

RNA interference is a gene regulatory mechanism in which the expression of specific genes is downregulated by endogenous microRNAs or by small interfering RNAs (siRNAs).

16 Oct 2020

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

16 Oct 2020

Researchers aim to identify disease tolerance mechanisms in sepsis patients

Sepsis is estimated to cause 11 million deaths every year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails due to unsuccessful attempts at modulating the immune response.

16 Oct 2020

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Key blood marker can lead to effective melanoma treatments

An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

16 Oct 2020

Governments must expand mental health and drug treatment services for young people

Governments must urgently expand mental health and drug treatment services before it’s too late, the Ted Noffs Foundation has said, warning that official data showing skyrocketing numbers of Victorians accessing crisis support signals the beginning of a national crisis.

16 Oct 2020

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

In just six months, the world's largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.

16 Oct 2020

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment, had a "rapid and complete response" to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center and the Georgetown Lombardi Comprehensive Cancer Center, both of whom are part of the Georgetown Lombardi Comprehensive Cancer Center Consortium.

16 Oct 2020

Scientists discover a novel antiviral strategy for treating COVID-19

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, and Professor Kwok Yung YUEN, Henry Fok Professor in Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU), has discovered a novel antiviral strategy for treatment of COVID-19.

16 Oct 2020

Study challenges current standard for managing blood pressure in people with spinal cord injury

New research from the International Collaboration on Repair Discoveries (ICORD) challenges the current standard for managing blood pressure in people with spinal cord injury (SCI).

16 Oct 2020

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

As scientists scramble to find effective vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent study published on the preprint server bioRxiv in October 2020 reports that the use of convalescent plasma to treat COVID-19 disease early in the course of the illness may be among the best available strategies at present.

16 Oct 2020

FDA reissues EUA for certain filtering face-piece respirators manufactured in China

Today, the U.S. Food and Drug Administration (FDA) reissued the Emergency Use Authorization (EUA) for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH).

16 Oct 2020

Drugs News and Research

Researchers describe how to assess if an antibiotic has a new mechanism of action

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Antispastic drug candidate could offer new hope for millions of patients suffering from spasticity

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Study uncovers novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness

Researchers develop new strategy to improve siRNA stability

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

Researchers aim to identify disease tolerance mechanisms in sepsis patients

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Key blood marker can lead to effective melanoma treatments

Governments must expand mental health and drug treatment services for young people

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Scientists discover a novel antiviral strategy for treating COVID-19

Study challenges current standard for managing blood pressure in people with spinal cord injury

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

FDA reissues EUA for certain filtering face-piece respirators manufactured in China

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News